共 50 条
- [1] Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck CancerINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 116 (03): : 533 - 543Caudell, Jimmy J.Torres-Saavedra, Pedro A.Rosenthal, David I.Axelrod, Rita S.Nguyen-Tan, Phuc FelixSherman, Eric J.Weber, Randal S.Galvin, James M.El-Naggar, Adel K.Konski, Andre A.Echevarria, Michelle I.Dunlap, Neal E.Shenouda, GeorgeSingh, Anurag K.Beitler, Jonathan J.Garsa, AdamBonner, James A.Garden, Adam S.Algan, OzerHarris, JonathanLe, Quynh-Thu
- [2] Long-Term Update of NRG Oncology RTOG 0522: A Randomized Phase III Trial of Concurrent Radiation and Cisplatin with or without Cetuximab in Locoregionally Advanced Head and Neck CancerINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1116 - 1117Caudell, J. J.Torres-Saavedra, P.Rosenthal, D. I.Axelrod, R.Nguyen-Tan, P. F.Sherman, E.Weber, R. S.Galvin, J. M.El-Naggar, A. K.Konski, A. A.Trotti, A.Dunlap, N. E.Shenouda, G.Singh, A. K.Beitler, J. J.Garsa, A. A., Jr.Birrer, M.Garden, A. S.Herman, T. S.Le, Q. T.
- [3] Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) : 2940 - +Ang, K. KianZhang, QiangRosenthal, David I.Nguyen-Tan, Phuc FelixSherman, Eric J.Weber, Randal S.Galvin, James M.Bonner, James A.Harris, JonathanEl-Naggar, Adel K.Gillison, Maura L.Jordan, Richard C.Konski, Andre A.Thorstad, Wade L.Trotti, AndyBeitler, Jonathan J.Garden, Adam S.Spanos, William J.Yom, Sue S.Axelrod, Rita S.
- [4] A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC).JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Ang, K. K.Zhang, Q. E.Rosenthal, D. I.Nguyen-Tan, P.Sherman, E. J.Weber, R. S.Galvin, J. M.Schwartz, D. L.El-Naggar, A. K.Gillison, M. L.Jordan, R.List, M. A.Konski, A. A.Thorstad, W. L.Trotti, A.Beitler, J. J.Garden, A. S.Spanos, W. J.Yom, S. S.Axelrod, R. S.
- [5] Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (04): : 687 - 699Minh Tam TruongZhang, QiangRosenthal, David I.List, MarcieAxelrod, RitaSherman, EricWeber, RandalPhuc Felix Nguyen-TanEl-Naggar, AdelKonski, AndreGalvin, JamesSchwartz, DavidTrotti, AndySilverman, CraigSingh, AnuragGodette, KarenBonner, James A.Jones, Christopher U.Garden, Adam S.Shenouda, GeorgeMatthiesen, ChanceQuynh-Thu LeBruner, Deborah
- [6] Cetuximab and Radiation Therapy Versus Cisplatin and Radiation Therapy for Locally Advanced Head and Neck Cancer: Long-Term Survival and Toxicity Outcomes of a Randomized Phase 2 TrialINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 107 (03): : 469 - 477Maddalo, MartaBorghetti, PaoloTomasini, DavideCorvo, RenzoBonomo, PierluigiPetrucci, AlessiaPaiar, FabiolaLastrucci, LucianaBonu, Marco LorenzoGreco, DianaCosta, LoredanaPegurri, LudovicaTriggiani, LucaBelgioia, LilianaDesideri, IsaccoGrisanti, SalvatoreBuglione, MichelaMagrini, Stefano Maria
- [7] Concomitant boost radiation and concurrent cisplatin for advanced head and neck carcinomas: Update of a phase II trial of the RTOG (99-14)INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S71 - S72Garden, ASHarris, JJones, CUTrotti, ACarrascosa, LACheng, JDSpencer, SAWeber, RAng, K
- [8] Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: A Phase II trial of the Radiation Therapy Oncology Group (RTOG 99-14)INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (05): : 1351 - 1355Garden, Adam S.Harris, JonathanTrotti, AndyJones, Christopher U.Carrascosa, LuisCheng, Jonathan D.Spencer, Sharon S.Forastiere, ArleneWeber, Randal S.Ang, K. Kian
- [9] Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trialINTERNATIONAL JOURNAL OF CANCER, 2019, 145 (01) : 295 - 305Li, Wen-FeiChen, Nian-YongZhang, NingHu, Guo-QingXie, Fang-YunSun, YanChen, Xiao-ZhongLi, Jin-GaoZhu, Xiao-DongHu, Chao-SuXu, Xiang-YingChen, Yuan-YuanHu, Wei-HanGuo, LingMo, Hao-YuanChen, LeiMao, Yan-PingSun, RuiAi, PingLiang, Shao-BoLong, Guo-XianZheng, Bao-MinFeng, Xing-LaiGone, Xiao-ChangLi, LingShen, Chun-YingXu, Jian-YuGuo, YingChen, Yu-MingZhang, FanLin, LiTang, Ling-LongLiu, Meng-ZhongMa, JunSun, Ying
- [10] Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical TrialJAMA ONCOLOGY, 2017, 3 (11) : 1520 - 1528Suntharalingam, MohanWinter, KathrynIlson, DavidDicker, Adam P.Kachnic, LisaKonski, AndreChakravarthy, A. BapsiAnker, Christopher J.Thakrar, HarishHoriba, NaomiDubey, AjayGreenberger, Joel S.Raben, AdamGiguere, JeffreyRoof, KevinVidetic, GregoryPollock, JondavidSafran, HowardCrane, Christopher H.